97-15844. Manufacturer of Controlled Substances; Notice of Application  

  • [Federal Register Volume 62, Number 116 (Tuesday, June 17, 1997)]
    [Notices]
    [Page 32824]
    From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
    [FR Doc No: 97-15844]
    
    
    -----------------------------------------------------------------------
    
    DEPARTMENT OF JUSTICE
    
    Drug Enforcement Administration
    
    
    Manufacturer of Controlled Substances; Notice of Application
    
        Pursuant to Section 1301.33 of Title 21 of the Code of Federal 
    Regulations (CFR), this is notice that on May 16, 1997, Dupont 
    Pharmaceuticals, The Dupont Merck Pharmaceutical Co., 1000 Steward 
    Avenue, Garden City, New York 11530, made application by renewal to the 
    Drug Enforcement Administration (DEA) for registration as a bulk 
    manufacturer of the basic classes of controlled substances listed 
    below:
    
    ------------------------------------------------------------------------
                        Drug                               Schedule         
    ------------------------------------------------------------------------
    Oxycodone (9143)...........................  II                         
    Hydrocodone (9193).........................  II                         
    Oxymorphone (9652).........................  II                         
    ------------------------------------------------------------------------
    
        The firm plans to manufacture the listed controlled substances to 
    make finished products.
        Any other such applicant and any person who is presently registered 
    with DEA to manufacture such substances may file comments or objections 
    to the issuance of the proposed registration.
        Any such comments or objections may be addressed, in quintuplicate, 
    to the Deputy Assistant Administrator, Office of Diversion Control, 
    Drug Enforcement Administration, United States Department of Justice, 
    Washington, D.C. 20537, Attention: DEA Federal Register Representative 
    (CCR), and must be filed no later than August 18, 1997.
    
        Dated: June 9, 1997.
    John H. King,
    Deputy Assistant Administrator, Office of Diversion Control, Drug 
    Enforcement Administration.
    [FR Doc. 97-15844 Filed 6-16-97; 8:45 am]
    BILLING CODE 4410-09-M
    
    
    

Document Information

Published:
06/17/1997
Department:
Drug Enforcement Administration
Entry Type:
Notice
Document Number:
97-15844
Pages:
32824-32824 (1 pages)
PDF File:
97-15844.pdf